Established in 2023, Crescent R&D integrates the acquisition of Archimedis Healthcare Limited, a leading Pharmaceutical Research and development facility based in Chennai, India, into the Crescent group.  

Crescent R&D has MHRA approved manufacturing capability for solid dosage form as well extensive laboratory expertise for the continued development of our portfolio.

The R&D expertise will allow the continued improvement and development of our existing portfolio and the development of new pharmaceutical dossiers to add to our extensive range.